BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 452141)

  • 1. [Biotransformation of prednisone to prednisolone in patients with liver cirrhosis].
    Madsbad S; Bjerregaard B; Henriksen JH; Juhl E; Kehlet H
    Ugeskr Laeger; 1979 May; 141(20):1325-8. PubMed ID: 452141
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired conversion of prednisone to prednisolone in patients with liver cirrhosis.
    Madsbad S; Bjerregaard B; Henriksen JH; Juhl E; Kehlet H
    Gut; 1980 Jan; 21(1):52-6. PubMed ID: 7364321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomogram for prednisone-prednisolone adjustment dose in patients with hypoalbuminemia.
    Centeno F; Robles G; Uribe M; Lozada SG; Suárez GI
    Rev Invest Clin; 1978; 30(1):35-9. PubMed ID: 635321
    [No Abstract]   [Full Text] [Related]  

  • 4. Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone.
    Schalm SW; Summerskill WH; Go VL
    Gastroenterology; 1977 May; 72(5 Pt 1):910-3. PubMed ID: 849821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of liver function on the metabolism of prednisone and prednisolone in humans.
    Renner E; Horber FF; Jost G; Frey BM; Frey FJ
    Gastroenterology; 1986 Apr; 90(4):819-28. PubMed ID: 3512355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of liquid diet on serum protein binding and prednisolone concentrations after oral prednisone.
    Uribe M; Schalm SW; Summerskill WH; Go VL
    Gastroenterology; 1976 Aug; 71(2):362-4. PubMed ID: 939399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of prednisone and prednisolone in human serum by high-performance liquid chromatography--especially on impaired conversion of corticosteroids in patients with chronic liver disease.
    Ui T; Mitsunaga M; Tanaka T; Horiguchi M
    J Chromatogr; 1982 Apr; 239():711-6. PubMed ID: 7096508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term therapy of chronic hepatitis].
    De Groote J; Maes H; Vandenbroucke J
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):15-7. PubMed ID: 5501420
    [No Abstract]   [Full Text] [Related]  

  • 9. Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.
    Powell LW; Axelsen E
    Gut; 1972 Sep; 13(9):690-6. PubMed ID: 4639403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the absorption of prednisone and prednisolone disodium phosphate after rectal administration.
    Halvorsen S; Myren J; Aakvaag A
    Scand J Gastroenterol; 1969; 4(7):582-4. PubMed ID: 5374927
    [No Abstract]   [Full Text] [Related]  

  • 11. Simultaneous determination of prednisolone, prednisone, cortisol, and cortisone in plasma by GC-MS: estimating unbound prednisolone concentration in patients with nephrotic syndrome during oral prednisolone therapy.
    Shibasaki H; Nakayama H; Furuta T; Kasuya Y; Tsuchiya M; Soejima A; Yamada A; Nagasawa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):164-9. PubMed ID: 18387858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal of prednisone and prednisolone by plasma exchange.
    Stigelman WH; Henry DH; Talbert RL; Townsend RJ
    Clin Pharm; 1984; 3(4):402-7. PubMed ID: 6467876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible metabolism and pharmacokinetics: application to prednisone-prednisolone.
    Wagner JG; DiSanto AR; Gillespie WR; Albert KS
    Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):387-405. PubMed ID: 7268190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.
    Frey FJ; Rüegsegger MK; Frey BM
    Br J Clin Pharmacol; 1986 Feb; 21(2):183-9. PubMed ID: 3954934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prednisone for chronic active hepatitis: pharmacokinetics and serum binding in patients with chronic active hepatitis and steroid major side effects.
    Uribe M; Go VL; Kluge D
    J Clin Gastroenterol; 1984 Aug; 6(4):331-5. PubMed ID: 6481116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of a prednisolone compound in human under normal and pathological conditions.
    Fehér T; Koref O; Tankó A; Bodrogi L; Poteczin E
    Arzneimittelforschung; 1975 Aug; 25(8):1314-7. PubMed ID: 52365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose prednisone treatment in severe ulcerative colitis.
    Kristensen M; Koudahl G; Fischerman K; Jarnum S
    Scand J Gastroenterol; 1974; 9(2):177-83. PubMed ID: 4818396
    [No Abstract]   [Full Text] [Related]  

  • 18. Kinetics and interconversion of prednisolone and prednisone studied with new radioimmunogassays.
    Meikle AW; Weed JA; Tyler FH
    J Clin Endocrinol Metab; 1975 Oct; 41(4):717-21. PubMed ID: 1176582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prednisone treatment of liver cirrhosis].
    Ugeskr Laeger; 1974 Jul; 136(30):1673-6. PubMed ID: 4428503
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioavailability assessment of a liquid prednisone preparation.
    Georgitis JW; Flesher KA; Szefler SJ
    J Allergy Clin Immunol; 1982 Oct; 70(4):243-7. PubMed ID: 7119300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.